Dermakare Pharmaceuticals Private Limited, a active private limited company, was established on 12 February 2011 in Lucknow, Uttar Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74900UP2011PTC043538. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹6.18 M.
It upholds a compliant status. Employing 48 professional, Its leadership includes Veshali Porwal (Director), Madhuri Mishra (Director), Archana (Director). Past directors included Manu Mishra, Laxmi Kant, Sumit Porwal. It holds ₹4.43 Cr open charges and ₹4.11 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at F-390 Transport Nagar Kanpur Road, Lucknow, Uttar Pradesh, 226012.
U74900UP2011PTC043538
043538
12 February 2011
₹2.00 Cr
₹6.18 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Dermakare Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Veshali Porwal | Director | 01 May 2013 | Current |
| Madhuri Mishra | Director | 15 Jul 2013 | Current |
| Archana | Director | 01 May 2013 | Current |
| Roop Chand Rastogi | Director | 12 Feb 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 May 2013 | Past |
| Pramod Abcsdd | Director | 24 May 2011 | Past |
| Pramod Abcsdd | Director | 15 Jul 2013 | Past |
| Pramod Abcsdd | Director | 01 May 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dermakare Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.48% increase. The company also saw a substantial improvement in profitability, with a 78.54% increase in profit. The company's net worth moved up by a moderate rise of 4.96%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Dermakare Pharmaceuticals had a public holding of 91.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹44,336,810.00
₹41,100,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jan 2022 | Others | ₹4.08 Cr | Open |
| 06 Aug 2021 | Axis Bank Limited | ₹3.54 M | Open |
| 29 Jun 2020 | Others | ₹5.40 M | Satisfied |
| 29 Nov 2014 | Others | ₹3.50 Cr | Satisfied |
| 29 Jan 2014 | Canara Bank | ₹0.70 M | Satisfied |
Explore comprehensive loan charge details -
Dermakare Pharmaceuticals has a workforce of 48 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Dermakare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dermakare Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Dermakare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Dermakare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
A charge with Others of Rs. 4.08 Cr registered on 28 Jan 2022 with Charge ID 100549646 was modified on 10 May 2022. was recorded as a recent event.
Progress on A charge registered on 29 Jun 2020 via Charge ID 100368401 with Others was fully satisfied on 10 Mar 2022. was documented.
Progress on A charge registered on 29 Nov 2014 via Charge ID 10535427 with Others was fully satisfied on 10 Mar 2022. was documented.
The activity A charge with Others amounted to Rs. 4.08 Cr with Charge ID 100549646 was registered on 28 Jan 2022. was completed.
The CIN of Dermakare Pharmaceuticals Private Limited is U74900UP2011PTC043538.
Dermakare Pharmaceuticals Private Limited is headquartered at F-390 Transport Nagar Kanpur Road, Lucknow, Uttar Pradesh, 226012.
Dermakare Pharmaceuticals Private Limited was incorporated on 12 February 2011.
The current directors of Dermakare Pharmaceuticals Private Limited are
The primary industry of Dermakare Pharmaceuticals Private Limited is Trade.
Dermakare Pharmaceuticals Private Limited is unlisted.
The authorized capital of Dermakare Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹6.18 M.
The compliance status of Dermakare Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX